The Protein Arginine N Methyltransferase 5 pipeline drugs market research report outlays comprehensive information on the Protein Arginine N Methyltransferase 5 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Protein Arginine N Methyltransferase 5 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Oncology, and Hematological Disorders which include the indications Solid Tumor, Non-Small Cell Lung Cancer, and Unspecified Hematological Disorders. It also reviews key players involved in Protein Arginine N Methyltransferase 5 targeted therapeutics development with respective active and dormant or discontinued products.
The Protein Arginine N Methyltransferase 5 pipeline targets constitutes close to 39 molecules. Out of which, approximately 38 molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase II, Phase I, IND/ CTA Filed, Preclinical, and Discovery stages are 5, 6, 5, 18, and 4 respectively. Similarly, the universities portfolio in Discovery comprises 1 molecule.
Protein Arginine N Methyltransferase 5 overview
Protein arginine N-methyltransferase 5 (PRMT5) is an enzyme that is encoded by the PRMT5 gene in humans. PRMT5 is an epigenetic enzyme that mainly represses transcription of target genes via symmetric dimethylation of arginine residues on histones. PRMT5 regulates developmental homeostatic and disease processes in vertebrates and invertebrates.
For a complete picture of Protein Arginine N Methyltransferase 5’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.